“medimmune” Archives

Entry Author Date Location
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Of Genzyme, Sanofi-Aventis, Biotech Buyout Gossip, and Angry Patients 08/05/10 Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off 12/08/09 Boston
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic 08/26/09 Boston
Seattle Genetics Snags Milestone 08/10/09 Seattle
U.S. Venture Funding Plummets (Yada Yada), But New England Less So—Region’s Top 10 Deals of Q1 04/20/09 Boston
Trubion Wins Patent Dispute With Genentech, Biogen Idec 09/11/08 Seattle
Seattle Genetics Gunning for the Market With “Empowered Antibody” For Cancer 06/14/08 Seattle
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process 06/05/08 Boston
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again 12/18/07 Boston
Biogen Idec on the Block; Icahn’s Interest in Buying the Firm Confirmed 10/12/07 Boston
Carl Icahn: Biogen Idec Marriage Broker? 08/27/07 Boston
Page 2 of 2 « previous page